Locations:
Search IconSearch

Tag: multiple sclerosis (MS)

18-NEU-733-Pediatric-MS-650×450

Pediatric-Onset MS: Study Confirms Some Features, Flags Others as Research Priorities

Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs

18-NEU-820-Generic-MS-Drugs-650×450

Generics and Biosimilars in Multiple Sclerosis: Navigating a New Therapy Landscape

What neurologists need to know about this emerging development

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-509-Nakamura-Volumetric-MRI-650×450

Making the Most of Brain Imaging Through Quantitative Volumetric Analysis

Applications in MS, neurodegenerative disease and epilepsy

17-NEU-4354-Fox-SPRINT-Study-650×450
October 31, 2017/Neurosciences/Research

SPRINT-MS: Ibudilast Shows Unprecedented Slowing of Brain Atrophy in Progressive MS

Paves way for phase 3 testing of novel treatment approach

17-NEU-4267-Ontaneda-650×450
September 27, 2017/Neurosciences/Research

Cleveland Clinic Leads PCORI-Funded Project to Guide Treatment Philosophy in MS

$10.6M award to help compare escalation with early highly effective treatment

17-NEU-716-Cohen-Stem-Cell-650×450

Stem Cell Therapies for Neurological Diseases: The Devil’s in the Details

Dr. Jeffrey Cohen on the challenges that temper the promise

16-NEU-2801-Ontaneda-650×450

Multiple Sclerosis: Where Do Efforts Stand Against Its Elusive Progressive Form?

New Lancet review brings specialists, generalists up to speed

BackPage 8 of 8Next

Advertisement

Ad